Fri Sep 20 08:40:49 UTC 2024: ## Institutional Investors Show Interest in OrthoPediatrics Corp. (KIDS)

**New York, NY (MarketBeat News) – September 20, 2024:** Several institutional investors have recently adjusted their holdings of OrthoPediatrics Corp. (NASDAQ:KIDS), a medical device company specializing in pediatric orthopedic products.

**Quest Partners LLC** entered the game in the second quarter, acquiring 1,170 shares worth approximately $34,000. Meanwhile, other investors increased their stakes:

* **Candriam S.C.A.** boosted its position by 33.1%, now owning 19,165 shares valued at $551,000.
* **Rhumbline Advisers** expanded its holdings by 19.0%, owning 26,613 shares worth $765,000.
* **Triodos Investment Management BV** increased its stake by 1.2%, holding 41,500 shares valued at $1,194,000.
* **Commonwealth Equity Services LLC** saw a 0.6% boost, now owning 72,935 shares valued at $2,098,000.
* **Bank of New York Mellon Corp** expanded its stake by 14.9%, holding 68,700 shares worth $1,976,000.

Collectively, hedge funds and institutional investors control 69.05% of OrthoPediatrics’ stock.

**Other Notable Developments:**

* OrthoPediatrics’ General Counsel, **Daniel J. Gerritzen**, sold 10,000 shares on August 21st at an average price of $29.30.
* Several equities research analysts have recently commented on the stock, with Truist Financial reiterating a “hold” rating, Needham & Company LLC reiterating a “buy” rating, and JMP Securities reiterating a “market outperform” rating.

**Company Overview:**

OrthoPediatrics Corp. develops and markets orthopedic implants, instruments, and braces specifically designed for children. The company offers products for a range of pediatric orthopedic needs, including trauma, deformity correction, scoliosis, and sports medicine.

**MarketBeat’s Perspective:**

This recent activity suggests a growing interest in OrthoPediatrics from institutional investors. Further analysis of the company’s financial performance, product development, and market position will be crucial to understanding the full scope of this investor interest.

Read More